These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 15106119)

  • 21. Successful control and impending elimination of measles in the Islamic Republic of Iran.
    Zahraei SM; Gouya MM; Azad TM; Soltanshahi R; Sabouri A; Naouri B; Alexander JP
    J Infect Dis; 2011 Jul; 204 Suppl 1():S305-11. PubMed ID: 21666178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The significance of epidemiological studies for progress of measles elimination].
    Mrozek-Budzyn D
    Przegl Epidemiol; 2010; 64(3):361-6. PubMed ID: 20976947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles vaccines and the potential for worldwide eradication of measles.
    Meissner HC; Strebel PM; Orenstein WA
    Pediatrics; 2004 Oct; 114(4):1065-9. PubMed ID: 15466106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in global measles control and mortality reduction, 2000-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(47):1237-41. PubMed ID: 18046301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When, and how, should we introduce a combination measles-mumps-rubella (MMR) vaccine into the national childhood expanded immunization programme in South Africa?
    Cameron NA
    Vaccine; 2012 Sep; 30 Suppl 3():C58-60. PubMed ID: 22939023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Caribbean experience in maintaining high measles vaccine coverage.
    Irons B; Dobbins JG;
    J Infect Dis; 2011 Jul; 204 Suppl 1():S284-8. PubMed ID: 21666175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global measles control and regional elimination, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Dec; 48(49):1124-30. PubMed ID: 10634347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunization Programme and Coverage against Measles and Rubella in Spain. Challenges for Achieving their Elimination].
    Limia Sánchez A; Molina Olivas M
    Rev Esp Salud Publica; 2015; 89(4):357-64. PubMed ID: 26580791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress toward the 2012 measles elimination goal--Western Pacific Region, 1990-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jun; 58(24):669-73. PubMed ID: 19553903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.
    Morice A; Carvajal X; León M; Machado V; Badilla X; Reef S; Lievano F; Depetris A; Castillo-Solórzano C
    J Infect Dis; 2003 May; 187 Suppl 1():S158-63. PubMed ID: 12721908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008.
    O'Connor PM; Liyanage JB; Mach O; Anand A; Ramamurty N; Balakrishnan MR; Singh S
    J Infect Dis; 2011 Jul; 204 Suppl 1():S396-402. PubMed ID: 21666190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained measles elimination in Australia and priorities for long term maintenance.
    Gidding HF; Wood J; MacIntyre CR; Kelly H; Lambert SB; Gilbert GL; McIntyre PB
    Vaccine; 2007 May; 25(18):3574-80. PubMed ID: 17300858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the United States.
    Kolasa MS; Klemperer-Johnson S; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S98-103. PubMed ID: 15106097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.
    Marin M; Nguyen HQ; Langidrik JR; Edwards R; Briand K; Papania MJ; Seward JF; LeBaron CW
    Clin Infect Dis; 2006 Feb; 42(3):315-9. PubMed ID: 16392073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress toward measles elimination--Southern Africa, 1996-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):585-9. PubMed ID: 10428097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.
    Best JM; Castillo-Solorzano C; Spika JS; Icenogle J; Glasser JW; Gay NJ; Andrus J; Arvin AM
    J Infect Dis; 2005 Dec; 192(11):1890-7. PubMed ID: 16267759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Measles Initiative: moving toward measles eradication.
    Christie AS; Gay A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S14-7. PubMed ID: 21666155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.